Skip to main content

Advertisement

SpringerLink
Log in

Differential expression of ABC transporters (MDR1, MRP1, BCRP) in developing human embryos

  • Original paper
  • Published:
Journal of Molecular Histology Aims and scope Submit manuscript

Abstract

Three ABC transporters (MDR1, MRP1, BCRP), belonging to the family of multidrug resistance (MDR) proteins, play a crucial role in the protection mechanisms during embryogenesis and mediate drug resistance in cancer cells. The distribution of these transporters in the series of human embryonal/fetal intestine, liver and kidneys of various stages of intrauterine development (IUD) by indirect two-step immunohistochemical method was investigated. The organ- and age-specific expression patterns of these transporters were depicted and compared with the expression in adult organs. The evaluation of intestine and liver samples demonstrate differences in expression pattern of ABC transporters during IUD. On the contrary, in kidneys the age-specific localization was not observed. However, the increasing positivity from the kidney surface towards deeper, more differentiated parts was found. Hopefully, our study may contribute to elucidation of the role of multidrug resistance (MDR) pathways during IUD in man.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  • Carlson BM (1999) Human embryology & developmental biology. Mosby, ISBN 0-8151-1458-3

  • Chandra P, Brouwer KL (2004) The complexities of hepatic drug transport: current knowledge and emerging concepts. Pharm Res 21:719–735

    Article  PubMed  CAS  Google Scholar 

  • Cui YJ, Chang X, Weaver YM, Klaassen D (2009) Tissue distribution, gender-divergent expression, ontogeny, and chemical induction of multidrug resistance transporter genes (Mdr1a, Mdr1b, Mdr2) in mice. Drug Metab Dispos 37:203–210

    Article  PubMed  CAS  Google Scholar 

  • Dean M (2001) The human ATP-binding casette (ABC) transporter superfamily. J Lipid Res 42:1007–1017

    PubMed  CAS  Google Scholar 

  • Deeley RG, Cole SP (2006) Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett. 580(4):1103–1111

    Article  PubMed  CAS  Google Scholar 

  • Dunwoodie SL (2009) The role of hypoxia in development of the mammalian embryo. Developmental Cell 17(6):755–773

    Article  PubMed  CAS  Google Scholar 

  • Hu C, Li H, Li J, Zhu Z, Yin S, Hao X, Yao M, Zheng S, Gu J (2008) Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling. Carcinogenesis 29(12):2289–2297

    Article  PubMed  CAS  Google Scholar 

  • Huls M, Brown CDA, Windass AS, Sayer R, van den Heuvel JMW, Heemskerk S, Russel FGM, Masereeuw R (2008) The breast cancer resistence protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int 73(2):220–225

    Article  PubMed  CAS  Google Scholar 

  • Jonker JW, Smit JW, Brinkhuis RF, Maliepaard M, Beijnen JH, Schellens JH, Schinkel AH (2000) Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst 92:1651–1656

    Article  PubMed  CAS  Google Scholar 

  • Konieczna A, Lichnovska R, Erdosova B, Ehrmann J (2009) The role of PPARs in MDR—a lesson from embryonic development. Neoplasma 56(4):279–283

    Article  PubMed  CAS  Google Scholar 

  • Krishnamurthy P, Schultz JD (2005) The ABC transporters Abcg2/Bcrp: role in hypoxia mediated survival. Biometals 18(4):349–358

    Article  PubMed  CAS  Google Scholar 

  • Lee CH, Bradley G, Zhang JT, Ling V (1993) Differential expression of P-glycoprotein genes in primary rat hepatocytes culture. J Cell Physiol 157(2):392–402

    Article  PubMed  CAS  Google Scholar 

  • Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH et al (2001) Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 61:3458–3464

    PubMed  CAS  Google Scholar 

  • Pore N, Jibin J, Sin S, Bernhard EJ, Maity A (2005) Act activation can augment HIF-1α expression by increasing translation through an mTOR-independent pathway. Proc Am Assoc Cancer Res Volume 46

  • Romsicki Y, Sharom FJ (1999) The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter. Biochechemistry 38:6887–6896

    Article  CAS  Google Scholar 

  • Rosati A, Maniori S, Decorti G, Candussio L, Giraldi T, Bartoli F (2003) Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. Dev Growth Differ 45:377–387

    Article  PubMed  CAS  Google Scholar 

  • Scherbakova EA, Stromskaya TP, EYu Rybalkina, Kalita OV, Stavrovskaya AA (2008) Role of the PTEN protein in the multidrug resistance of prostate cancer cells. Cell Mol Biol 42(3):430–435

    CAS  Google Scholar 

  • Schinkel AH, Wagenaar E, van Deemter L et al (1995) Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 96:1698–1705

    Article  PubMed  CAS  Google Scholar 

  • Smit JW, Schinkel AH, Weert B, Meijer DK (1998) Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice in which both mdr1a and mdr1b genes have been disrupted. Br J Pharmacol 124:416–424

    Article  PubMed  CAS  Google Scholar 

  • Sparreboom A, van Asperen J, Mayer U, Schinkel AH, Smit JW, Meijer DKF, Borst P, Nooijen WJ, Beijnen JH, Van Tellingen O (1997) Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci USA 94:2031–2035

    Article  PubMed  CAS  Google Scholar 

  • Stewart CF, Leggas M, Schuetz JD, Panetta JC, Cheshire PJ, Peterson J, Daw N, Jenkins JJ III, Gilbertson R, Germain GS, Harwood FC, Houghton PJ (2004) Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in mice. Cancer Res 64:7491–7499

    Article  PubMed  CAS  Google Scholar 

  • Tramonti G, Romiti N, Norpoth M, Chieli E (2001) P-glycoprotein in HK-2 proximal tubule cell line. Ren Fail 23(3–4):331–337

    Article  PubMed  CAS  Google Scholar 

  • van Kalken CK, Giaccone G, van der Valk P, Kuiper CM, Hadisaputro MM, Bosma SA, Scheper RJ, Meijer CJ, Pinedo HM (1992) Multidrug resistance gene (P-glycoprotein) expression in the human fetus. Am J Pathol 141:1063–1072

    PubMed  Google Scholar 

  • Wijnholds J, Scheffer GL, van der Valk M, van der Valk P, Beijnen JH, Scheper RJ, Borst P (1998) Multidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage. J Exp Med 188(5):797–808

    Article  PubMed  CAS  Google Scholar 

  • Yue W, Abe K, Brouwer KLR (2009) Knocking down breast cancer resistance protein (Bcrp) by adenoviral vector-mediated RNA intereferance (RNAi) in sandwich-cultured rat hepatocytes: a novel tool to assess the contribution of Bcrp to drug biliary excretion. Mol. Pharmaceutics 6(1):134–143

    Article  CAS  Google Scholar 

  • Zhou S, Morris JJ, Barnes Z (2002) Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc Natl Acad Sci USA 99:12339–12344

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank to Mrs. Eva Kašpárková and Mrs. Eva Nezhybová for excellent technical support. This study was supported by MSM 619 895 9216, CZ 1.07/2.3.00/20.0019, LF_2011_009.

Author information

Authors and Affiliations

  1. Department of Histology and Embryology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic

    A. Konieczna, B. Erdösová, R. Lichnovská, M. Jandl, K. Čížková & J. Ehrmann

  2. Institute of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic

    J. Ehrmann

Authors
  1. A. Konieczna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Erdösová
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Lichnovská
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Jandl
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Čížková
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Ehrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Konieczna.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Konieczna, A., Erdösová, B., Lichnovská, R. et al. Differential expression of ABC transporters (MDR1, MRP1, BCRP) in developing human embryos. J Mol Hist 42, 567–574 (2011). https://doi.org/10.1007/s10735-011-9363-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10735-011-9363-1

Keywords

Search

Navigation